An Introduction to Machine Learning in the Pharmaceutical Industry [Video]

Machine learning in the pharmaceutical industry is the practical use of algorithms that learn patterns from data to support prediction, prioritisation, and early signal detection across discovery, development, and post-approval work. In this explainer, we break down what ‘machine learning’ means in a pharma context, how it differs from more traditional analytics, and why it can be valuable when data are high-dimensional, messy, or evolving, while still relying on strong statistical thinking, validation, and governance.

You’ll learn where machine learning is already being applied today, including target identification and compound screening in discovery, operational and design support in clinical trials, and signal detection in pharmacovigilance. We also explain why regulated use is less about whether you can use these methods and more about whether you can control them, with clear documentation, data integrity, audit trails, and version control, especially when models are updated over time.

We walk through practical considerations teams need to get right:

• Choosing the method based on the question, not the hype

• Data quality risks, including missingness, inconsistency, and bias
• Generalisability, and why external validation and performance monitoring matter
• Integration into workflows so outputs are trusted and acted on
• Cross-functional collaboration across data science, statistics, clinical, and operations

Finally, we address common misconceptions, like the idea that machine learning is automatically better, or that it removes the need for human judgement. In reality, impact depends on context, implementation, and whether stakeholders can justify and use the outputs responsibly.

At Quanticate, our biometrics teams help sponsors apply machine learning approaches in ways that are scientifically rigorous, well governed, and aligned with regulated decision making. Request a consultation today.